AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...
Medicare will begin capping prescription drug costs at $2,000 annually from January 1—a move that's widely expected to benefit millions of Americans.